Comment on 'Existing prognostic models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma'.
1] Asbestos Diseases Research Institute, Sydney, New South Wales, Australia [2] Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, New South Wales, Australia.
S C-H
SC
Kao
1] Asbestos Diseases Research Institute, Sydney, New South Wales, Australia [2] Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia.
N
N
van Zandwijk
1] Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia [2] Department of Medical Oncology, Royal North Shore Hospital, Sydney, New South Wales, Australia.
S
S
Clarke
D014408:Biomarkers, Tumor; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality*; D008214:Lymphocytes / Q000166:cytology*; D008297:Male; D008654:Mesothelioma / Q000401:mortality*; D009504:Neutrophils / Q000166:cytology*
D014408:Biomarkers, Tumor